Bladder Cancer
Bladder cancer originates from the urothelium, the lining of the bladder.
Most cases are transitional cell carcinoma, presenting with painless hematuria.
Early detection and appropriate endoscopic or surgical treatment can lead to long-term cure, especially for non-muscle invasive disease.
Overview And Clinical Background
Epidemiology and etiology
Bladder cancer primarily affects older adults and is strongly associated with smoking and chemical exposure.
It is categorized into non-muscle invasive, muscle-invasive, and metastatic forms.
Symptoms, Signs And Presentation
Classic presentation includes visible blood in urine without pain.
Some patients report frequency or urgency.
Diagnosis Methods And Investigations
Endoscopy and imaging
Cystoscopy with biopsy confirms diagnosis.
Imaging assesses local invasion and metastasis.
Treatment Options And Surgical Techniques
Treatment varies by stage — endoscopic resection for superficial tumors, radical cystectomy for invasive disease, and intravesical therapy for recurrence prevention.
Recovery, Risks And Prognosis
Non-muscle invasive disease has excellent survival.
Lifelong follow-up with cystoscopy is essential due to recurrence risk.
Why Choose Us
CureU Healthcare offers comprehensive urologic oncology services, including minimally invasive TURBT, advanced cystectomy, and modern intravesical therapy.
Our focus is on early detection and bladder preservation where possible.
Conclusion
Bladder cancer, though common, is highly treatable when detected early.
Ongoing surveillance ensures sustained disease control.
